$CCRN

Veizaga Marvin sold (to issuer) $640K of CCRN

Veizaga Marvin (Chief Accounting Officer) sold (to issuer) 48,277 shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($0.64M total) across 2 trades on 2026-07-21.

Original reporting
SEC EDGAR · Veizaga Marvin
Published Jul 21, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CCRN
Neutral
medium confidence
Mentioned
$CCRN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

The disclosure updates ownership/transaction details for the CFO but does not provide new financial results, guidance, contracts, or regulatory actions.

02

Market read

Traders may note insider selling activity, but the filing alone is unlikely to drive a material repricing without accompanying fundamental catalysts.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, but the transaction code is 'D' (sale to issuer), which can be operational rather than a discretionary market-timing signal.

Relevance 5/10Novelty 3/10Timing: Filed same day as the insider sale (2026-07-21).

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Cross Country Healthcare (CCRN).

Company-level read

Ticker impact

$CCRNNeutralMedium confidence
Context

Cross Country Healthcare disclosed a Form 4 sale to the issuer by CFO Veizaga Marvin of 48,277 shares at $13.25 on 2026-07-21.

Expected impact

Likely minimal near-term price impact; any effect is more sentiment/flow-related than fundamentals.

Evidence & confidence

Form 4 insider sales are typically low-signal for valuation unless tied to unusual circumstances; the filing provides transaction size and price but no new operating or guidance information.

Market effects

No clear sector read-through from a single insider sale to the issuer.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity management or a planned issuer buyback participation mechanism, so it may not reflect bearish fundamentals.

Key entities

  • CROSS COUNTRY HEALTHCARE INC

    Subject of the Form 4 insider transaction disclosure.

  • Veizaga Marvin

    Chief Accounting Officer who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).